share_log

Theravance Biopharma | SC TO-C: Written communication relating to an issuer or third party tender offer

SEC ·  Jul 13, 2022 16:57
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more